New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
Watch interviews from industry experts at this year’s American Association of Cancer Research (AACR) Annual Meeting
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
The all-new rapifleX™ extends MALDI leadership in protein characterization, biologics development and QC, as well as in Mass Spectrometry Imaging (MSI)
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Future joint collaborations are expected as work continues to unlock the full clinical and research potential of both technologies
Reference data set from Horizon affirms proven accuracy of GeneReader workflow
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting
Chromatrap® has announced a new 96-well high throughput purification plate for production of ultra-pure DNA
Download our new guide and learn how you can optimize your NGS workflow
Learn how digital PCR is advancing cancer genetics research at Louisiana State University Health Sciences Center
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Interlab comparison demonstrates Circulogene’s blood-drop-volume liquid biopsy assay is fastest, most accurate process to date for tracking and treating cancer
Life science companies combine expertise to enhance transcriptome research
BioTek Instruments, Inc. presented with Scientists' Choice Award® at AACR
RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Share your expertise and vote for the product that made most difference to your research in 2015